Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries
1 other identifier
interventional
507
1 country
1
Brief Summary
Patients are often counseled to keep a surgical wound dry for 2 to 3 days. The rationale is likely to decrease the risk of infection and bleeding. However, this has never been formally studied. Patient's routines are likely disrupted when they are asked to avoid wetting the area. The investigators will perform a controlled study to determine if avoidance of post-operative wetting is necessary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2013
CompletedFirst Posted
Study publicly available on registry
January 23, 2013
CompletedStudy Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2020
CompletedNovember 1, 2021
September 1, 2020
7 years
January 18, 2013
October 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative wound infection
Post-operative day 7 to 14
Secondary Outcomes (3)
Incidence of post-operative bleeding complications
Post-operative day 7 to 14
Scar appearance
6 months post-operatively (+-5 days)
Skin Specific Quality of Life
Post-operative days 7 to14
Study Arms (2)
Early Water Exposure
ACTIVE COMPARATORThe Intervention group will receive written and verbal instructions to remove the dressing after 6 hours and wet the wound for at least 10 minutes. Wetting of the wound will include shower, tub bath, or pool exposure.
Standard Care
NO INTERVENTIONThe Standard Care group will receive standard wound care instructions and verbal education by the staff to keep the dressing dry and intact for 48 hours.
Interventions
The Early Water Exposure (Intervention) group will receive written and verbal instructions to remove the dressing after 6 hours and wet the wound for at least 10 minutes. Wetting of the wound will include shower, tub bath, or pool exposure. On subsequent days, all participants, regardless of group assignment, will wash the wound daily with soap and water, reapply white petrolatum and a dry dressing.
Eligibility Criteria
You may qualify if:
- subjects are capable of giving informed consent
- patients undergoing any surgical treatment of benign and malignant lesions by any physician in the Dermatology department consisting of:
- standard excisional surgery or Mohs micrographic surgery with immediate reconstruction
- reconstruction with primary linear closure or adjacent tissue transfer with one or two layers of suture
You may not qualify if:
- pregnancy
- age younger than 18 years
- will not be returning to the dermatology clinic in 7-14 days for suture removal
- documented or suspected infection of the site prior to surgery
- current treatment with systemic antibiotic therapy
- staged excisions
- delayed or staged reconstructions
- wounds repaired with skin or cartilage grafts
- management with secondary intention healing
- surgical site on or near a mucosal surface where standard dressings are not typically used (eyelid, vermilion, etc.)
- patients receiving prophylactic antibiotics
- patients deemed on a case-by-case basis by their surgeon to have a high risk of post-operative bleeding and requiring prolonged application of a pressure dressing
- history of skin sensitivity or reaction to white petrolatum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Related Publications (12)
Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw. 2010 Aug;8(8):888-96. doi: 10.6004/jnccn.2010.0066.
PMID: 20870635BACKGROUNDLi J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007 Jan-Feb;25(1):9-18. doi: 10.1016/j.clindermatol.2006.09.007.
PMID: 17276196BACKGROUNDMenke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007 Jan-Feb;25(1):19-25. doi: 10.1016/j.clindermatol.2006.12.005.
PMID: 17276197BACKGROUNDWINTER GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature. 1962 Jan 20;193:293-4. doi: 10.1038/193293a0. No abstract available.
PMID: 14007593BACKGROUNDRatz, J.L. Textbook of dermatologic surgery, (Lippincott-Raven, Philadelphia, 1998).
BACKGROUNDRobinson, J.K. Surgery of the skin : procedural dermatology, (Elsevier Mosby, Philadelphia, 2005).
BACKGROUNDWolcott R, Dowd S. The role of biofilms: are we hitting the right target? Plast Reconstr Surg. 2011 Jan;127 Suppl 1:28S-35S. doi: 10.1097/PRS.0b013e3181fca244.
PMID: 21200270BACKGROUNDSmack DP, Harrington AC, Dunn C, Howard RS, Szkutnik AJ, Krivda SJ, Caldwell JB, James WD. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA. 1996 Sep 25;276(12):972-7.
PMID: 8805732BACKGROUNDChren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997 Nov;133(11):1433-40.
PMID: 9371029BACKGROUNDTsao S, Yao M, Tsao H, Henry FP, Zhao Y, Kochevar JJ, Redmond RW, Kochevar IE. Light-activated tissue bonding for excisional wound closure: a split-lesion clinical trial. Br J Dermatol. 2012 Mar;166(3):555-63. doi: 10.1111/j.1365-2133.2011.10710.x. Epub 2012 Jan 19.
PMID: 22032650BACKGROUNDvan de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005 Aug;116(2):514-22. doi: 10.1097/01.prs.0000172982.43599.d6.
PMID: 16079683BACKGROUNDSchuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80. doi: 10.1007/BF01068419.
PMID: 3450848BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Todd V Cartee, MD
Milton S. Hershey Medical Center
- PRINCIPAL INVESTIGATOR
Joslyn S Kirby, MD
Milton S. Hershey Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Dermatology
Study Record Dates
First Submitted
January 18, 2013
First Posted
January 23, 2013
Study Start
March 1, 2013
Primary Completion
March 16, 2020
Study Completion
October 16, 2020
Last Updated
November 1, 2021
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share